Cardiopulmonary Interventions to Prolong Survival in Patients with Duchenne Muscular Dystrophy
Duchenne muscular dystrophy (DMD) is caused by mutations in the dystrophin gene on the X chromosome at Xp21. DMD affects 1 of every 3,500 live male births. Progression of muscular weakness leads to loss of ambulation by 12 years of age, and the development of scoliosis is marked by the early teenage years.
KeywordsBrain Natriuretic Peptide Duchenne Muscular Dystrophy Duchenne Muscular Dystrophy Duchenne Muscular Dystrophy Patient Noninvasive Positive Pressure Ventilation
- 4.Birnkrant DJ, Panitch HB, Benditt JO, Boitano LJ, Carter ER, Cwik VA et al (2007) American College of Chest Physicians consensus statement on the respiratory and related management of patients with Duchenne muscular dystrophy undergoing anesthesia or sedation. Chest 132:1977–1986PubMedCrossRefGoogle Scholar